- Trials with a EudraCT protocol (448)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (4)
448 result(s) found for: Morphology.
Displaying page 1 of 23.
EudraCT Number: 2005-004170-25 | Sponsor Protocol Number: MH-110 | Start Date*: Information not available in EudraCT |
Sponsor Name:Bracco Imaging S.p.A. | ||
Full Title: A PHASE III, MULTI-CENTER, OPEN-LABEL STUDY TO EVALUATE SAFETY AND EFFICACY OF MULTIHANCE® AT THE DOSE OF 0.10 mmol/kg IN MAGNETIC RESONANCE IMAGING OF THE CENTRAL NERVOUS SYSTEM IN PEDIATRIC PA... | ||
Medical condition: imaging diagnosis of highly suspected or known brain and/or spine disease, which are known to impair the Blood Brain Barrier Function | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) BE (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004612-97 | Sponsor Protocol Number: CEC-4/CEL | Start Date*: 2021-08-12 | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: A phase IIb, double-blind, randomised, placebo-controlled trial to evaluate the efficacy and tolerability of ZED1227 in celiac disease subjects experiencing symptoms despite gluten-free diet | |||||||||||||
Medical condition: Treatment of celiac disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) LT (Ongoing) DE (Ongoing) NO (Ongoing) EE (Ongoing) IE (Ongoing) AT (Ongoing) IT (Ongoing) SE (Ongoing) ES (Ongoing) PL (Ongoing) BG (Ongoing) HR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003359-33 | Sponsor Protocol Number: MABS06 | Start Date*: 2023-06-21 | |||||||||||
Sponsor Name:MUMC | |||||||||||||
Full Title: Assess efficacy of intra-arterial autologous myogenic stem cell therapy for m.3243A>G mutation carriers | |||||||||||||
Medical condition: Mitochondrial myopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003946-18 | Sponsor Protocol Number: GDX-44-011 | Start Date*: 2019-05-03 | |||||||||||
Sponsor Name:GUERBET | |||||||||||||
Full Title: Efficacy and safety of gadopiclenol for body magnetic resonance imaging (MRI) | |||||||||||||
Medical condition: Patients presenting with know or suspected enhancing abnormality(ies) and/or lesion(s) in at least one body region among head & neck, thorax (including breast), abdomen (including liver, pancreas a... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) HU (Completed) BG (Completed) DE (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004364-66 | Sponsor Protocol Number: BMR111-208 | Start Date*: 2019-10-22 | |||||||||||
Sponsor Name:BioMarin Pharmaceutical Inc. | |||||||||||||
Full Title: A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children with Achondroplasia | |||||||||||||
Medical condition: Achondroplasia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001855-10 | Sponsor Protocol Number: SNAP1 | Start Date*: 2019-01-22 | |||||||||||
Sponsor Name:Department of Ophtalmology, Rigshospitalet-Glostrup | |||||||||||||
Full Title: Steroids and Non-steroidal Anti-inflammatory drugs in the Postoperative regime after trabeculectomy. An investigator-initiated randomized study (The SNAP study) | |||||||||||||
Medical condition: Medically uncontrolled glaucoma that requires filtration surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004746-33 | Sponsor Protocol Number: 310123 | Start Date*: 2008-09-17 | |||||||||||
Sponsor Name:Bayer HealthCare Pharmaceuticals INC | |||||||||||||
Full Title: A multicenter, randomized, double-blind, crossover, phase 3 study to determine the safety and efficacy of gadobutrol 1.0 molar (Gadovist®) in patients referred for contrast-enhanced MRI of the cent... | |||||||||||||
Medical condition: Male and female patients of any ethnic group who are referred for a contrast-enhanced MRI of the CNS based on current clinical symptoms or results of a previous imaging procedure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005943-27 | Sponsor Protocol Number: 975 | Start Date*: 2007-06-01 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Evaluation of the retinal electrofisiological response in patients with compensated GLAUCOMA POAG in treatment with epigallocatechin-gallate Epinerve . | |||||||||||||
Medical condition: glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005700-24 | Sponsor Protocol Number: SC | Start Date*: 2015-08-17 | |||||||||||
Sponsor Name:Abteilung für Augenheilkunde, AKH Linz | |||||||||||||
Full Title: Aqueous Humor cytokine Levels following intravitreal ranibizumab or dexamethasone therapy in patients with diabetic macular edema | |||||||||||||
Medical condition: Diabetic Retinopathy and diabetic macular edema are leading causes for visual loss and blindness in young adults around the world. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001617-21 | Sponsor Protocol Number: 72864 | Start Date*: 2020-08-27 |
Sponsor Name:Aarhus University Hospital | ||
Full Title: The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed with Wild-Type Transthyretin Cardiac Amyloidosis. | ||
Medical condition: Wild-Type Transthyretin Cardiac Amyloidosis | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003759-11 | Sponsor Protocol Number: FI 1 | Start Date*: 2007-03-09 |
Sponsor Name:BKH Schwaz | ||
Full Title: Autologous myoblasts for treatment of anal incontinence due to anal sphincter defects | ||
Medical condition: Fecal (anal) inconinence caused by ruptures/ traumas of the external anal sphincter | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006871-19 | Sponsor Protocol Number: 121206 | Start Date*: 2007-08-03 |
Sponsor Name:Universitätsklinik für Augenheilkunde und Optometrie, MUW | ||
Full Title: | ||
Medical condition: Macular changes after vitroretinal surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002125-32 | Sponsor Protocol Number: 308683 | Start Date*: 2005-12-22 |
Sponsor Name:Bayer Schering Pharma AG | ||
Full Title: A multicenter, open, randomized, parallel-group comparison to assess the safety and efficacy of the oral contraceptive SH T 00186 D (0.02 mg ethinylestradiol as betadex clathrate and 3 mg drospiren... | ||
Medical condition: healthy volunteers requesting oral contraception | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004959-39 | Sponsor Protocol Number: CRFB002A2405 | Start Date*: 2013-05-10 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 24-month, phase IIIb, randomized, double-masked, multicenter study assessing the efficacy and safety of two treatment regimens of 0.5 mg ranibizumab intravitreal injections guided by functional a... | |||||||||||||
Medical condition: Visual impairment due to neovascular AMD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) LT (Prematurely Ended) ES (Prematurely Ended) IE (Prematurely Ended) DE (Prematurely Ended) SK (Prematurely Ended) AT (Prematurely Ended) IT (Prematurely Ended) GB (Prematurely Ended) GR (Completed) SE (Completed) FI (Completed) PT (Completed) HU (Completed) NL (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000228-20 | Sponsor Protocol Number: 16012020001 | Start Date*: 2020-08-28 |
Sponsor Name:Medical University of Graz | ||
Full Title: Probiotic dietary Intervention in Polycystic Ovary Syndrome – A Randomized Controlled Trial | ||
Medical condition: Polycystic Ovary Syndrome (PCOS) is a hormonal and metabolic disorder affecting up to 20 percent of women worldwide, depending on diagnostic criteria. A very common definition of PCOS based on the ... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004364-35 | Sponsor Protocol Number: CETB115AUS01T | Start Date*: 2018-07-25 |
Sponsor Name:National Heart, Lung, and Blood | ||
Full Title: Eltrombopag added to standard immunosuppression in treatment-naïve severe aplastic anemia. | ||
Medical condition: Severe aplastic anemia (SAA) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: (No results available) |
EudraCT Number: 2011-003137-33 | Sponsor Protocol Number: | Start Date*: 2011-10-20 |
Sponsor Name:Pia österlund and Helena Isoniemi | ||
Full Title: Open-label, single-arm, phase II study of bevacizumab (AVASTIN) in combination with alternating Xeliri and Xelox as first-line treatment of patients with metastatic colorectal cancer | ||
Medical condition: metastatic colorectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002675-17 | Sponsor Protocol Number: TIGER-BVS | Start Date*: 2014-05-30 |
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | ||
Full Title: Ticagrelor and absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization | ||
Medical condition: Chronic total coronary occlusion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000783-42 | Sponsor Protocol Number: SDX-PL/001/2016 | Start Date*: 2016-09-19 | |||||||||||
Sponsor Name:Alfa Wassermann Polska Sp. z o.o. | |||||||||||||
Full Title: A phase 3, prospective, open, pilot, monocentric study to evaluate the effect of sulodexide administered at registered dose on morphology and functional properties of the venous endothelium in pati... | |||||||||||||
Medical condition: chronic venous insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004109-15 | Sponsor Protocol Number: 1ABC | Start Date*: 2017-12-13 | |||||||||||
Sponsor Name:Medical University of Warsaw | |||||||||||||
Full Title: Evaluation of the safety and efficacy of the treatment of chronic wounds in diabetic foot syndrome with the use of autologous stem cells isolated from adipose tissue - within the project: "Therapeu... | |||||||||||||
Medical condition: Diabetic foot ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.